Skip to main content
Log in

Evaluation of breast cancer incidence: is the increase due entirely to mammographic screening?

  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Objectives: To examine the trends in the incidence rates of breast cancer in a population with mammographic screening and in the unscreened women within that population.

Methods: Data consisted of incident cases of breast cancer notified to the Victorian Cancer Registry in Victoria, Australia, between 1988 and 1996 and cases detected in the population-based BreastScreen Program. These data were grouped by age (25–39, 40–49, 50–59, 60–69 and ≥70 years of age) and size of tumor (≤10 mm, > 10–≤15 mm, and > 15mm). Poisson regression modeling was used to examine trends by age, tumor size, calendar year and availability of screening.

Results: The incidence rate of breast cancer in the total population increased between 1988 and 1996. The greatest increase was seen after 1993 when population-based screening became available. In unscreened women, modeling demonstrated a statistically significant (p < 0.01) 1.5% annual increase in the incidence rate. The annual increase in this rate differed by size of tumor and was approximately 8% (p < 0.01) for small tumors (≤ 10 mm) but not significant for tumors > 10 mm. The greatest increase was in small tumors for women ≥ 50 years of age.

Conclusion: The incidence of breast cancer has increased since population-based mammographic screening was introduced in 1994. The rate in unscreened women also showed a significant increase. This was greatest in small tumors for women ≥ 50 years of age. Whether this will translate into an increase in mortality is uncertain and long-term monitoring is required to determine if cohort and period effects impact on the underlying incidence of breast cancer in Victoria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jelfs P, Coates M, Giles G, et al. (1996) Cancer in Australia 1989–1990 (with projections to 1995). Canberra: Australian Institute of Health and Welfare.

    Google Scholar 

  2. Giles GG (1985) Victorian Cancer Registry 1982 Statistical Report. Melbourne: Anti-Cancer Council of Victoria.

    Google Scholar 

  3. Giles G (1998) Victorian Cancer Registry, Summary Tables 1995, Incidence and Mortality. Melbourne: Cancer Epidemiology Centre, Anti-Cancer Council of Victoria.

    Google Scholar 

  4. Hurley SF, Kaldor JM (1992) The benefits and risks of mammographic screening for breast cancer. Epidemiol Rev 14: 101-130.

    Google Scholar 

  5. Day NE (1991) Screening for breast cancer. Bri Med Bull 47: 400-415.

    Google Scholar 

  6. Kricker A, Jelfs P (1996) Breast Cancer in Australian Women 1921–1994. Canberra: Australian Institute of Health and Welfare.

    Google Scholar 

  7. McCann J, Stockton D, Day N (1998) Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis. J Med Screen 5: 42-48.

    Google Scholar 

  8. Lantz PM, Remington PL, Newcomb PA (1991) Mammography screening and increased incidence of breast cancer in Wisconsin. J Natl Cancer Inst 83: 1540-1546.

    Google Scholar 

  9. White E, Yul Lee C, Kristal AR (1990) Evaluation of the increase in breast cancer incidence in relation to mammography use. J Natl Cancer Inst 82: 1546-1552.

    Google Scholar 

  10. Feuer EJ, Wun L-M (1992) How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? Am J Epidemiol 136: 1423-1436.

    Google Scholar 

  11. Schouten LJ, de Rijke JM, Schlangen JT, Verbeek ALM (1998) Evaluation of the effect of breast cancer screening by record linkage with the cancer registry, the Netherlands. J Med Screen 5: 37-41.

    Google Scholar 

  12. Wun L-M, Feuer E, Miller B (1995) Are increases in mammographic screening still a valid explanation for trends in breast cancer incidence in the United States. Cancer Causes Control 60: 135-144.

    Google Scholar 

  13. Quinn M, Allen E (1995) Changes in incidence and mortality from breast cancer in England and Wales since the introduction of screening. BMJ 311: 1391-1395.

    Google Scholar 

  14. Brewster D, Everington D, Harkness E, Gould A, Warner J (1996) Incidence and mortality from breast cancer since the introduction of screening. BMJ 312: 638-639.

    Google Scholar 

  15. Miller B, Feuer E, Hankey B (1991) The increasing incidence of breast cancer since 1982: relevance of early detection. Cancer Causes Control 2: 67-74.

    Google Scholar 

  16. Prior P, Woodman CBJ, Wilson S, Threlfall AG (1996) Reliability of underlying incidence rates for estimating the effect and efficiency of screening for breast cancer. J Med Screen 3: 119-122.

    Google Scholar 

  17. Giles G, Farrugia H, Silver B, Staples M (1992) A Guide to the Victorian Cancer Registry. Canstat. Melbourne: Anti-Cancer Council of Victoria.

    Google Scholar 

  18. Australian Bureau of Statistics (1988–96) Estimated Resident Population by Sex and Age. States and Territories of Australia. Canberra: ABS.

    Google Scholar 

  19. BreastScreen Victoria (1995) Annual Statistical Report 1994. Melbourne.

  20. BreastScreen Victoria (1996) Annual Statistical Report 1995. Melbourne.

  21. BreastScreen Victoria (1997) Annual Statistical Report 1996. Melbourne.

  22. Smith PG (1992) Comparison between registries: age-standardized rates. In: Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, eds. Cancer Incidence in Five Continents. Lyon: International Agency for Research on Cancer, vol. VI, pp. 865-870.

    Google Scholar 

  23. Francis B, Green M, Payne C, et al., eds (1993) The GLIM system: Release 4 Manual. Oxford: Oxford University Press.

    Google Scholar 

  24. Giles G, Farrugia H, Silver B, Staples M (1992) Victorian Cancer Registry 1988 Statistical Report. Melbourne: Anti-Cancer Council of Victoria.

    Google Scholar 

  25. Collaborative Group on Hormonal Factors and Breast Cancer (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108 411 women without breast cancer. Lancet 350: 1047-1059.

    Google Scholar 

  26. Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies. Lancet 347: 1713-1727.

    Google Scholar 

  27. Kelsey J, Bernstein L (1996) Epidemiology and prevention of breast cancer. Annu Rev Pub Health 1996; 17: 47-67.

    Google Scholar 

  28. Barratt A, Cockburn J, Lowe J, Paul C, Perkins J, Redman S (1997) Report on the 1996 Breast Health Survey. Sydney: National Health and Medical Research Centre, National Breast Cancer Centre.

    Google Scholar 

  29. Schofield P, Cockburn J, Hill D, Reading D. Encouraging attendance at a screening mammography programme: determinants of response to different recruitment strategies. J Med Screen 1: 144-149.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harmer, C., Staples, M. & Kavanagh, A.M. Evaluation of breast cancer incidence: is the increase due entirely to mammographic screening?. Cancer Causes Control 10, 333–337 (1999). https://doi.org/10.1023/A:1008949819969

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1008949819969

Navigation